Advertisement

New Horizons in Neuromodulation

  • Michael Gofeld
Neuromodulation (M Gofeld, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Neuromodulation

Abstract

Electrical stimulation of the nervous system is a method used for several centuries which just in the past decades received wide recognition as an effective and safe modality in the management of neuropathic pain and other maladies. Explosion of new technologies and discovery of new neuromodulation targets are two parallel and interconnected processes. Using a paraphrase from the famous novel of Samuel Sham, The House of God, one can say that there is no nervous tissue in the human body that cannot be reached with a stimulating lead directed by a good strong arm. Neuromodulation devices are being used for the stimulation of the entire nervous system, from the cutaneous terminals to brain centers. Autonomic regulation is also subject to stimulation via implanted devices. Future research and development is tightly related to the process of discovery, experimental courage, and philosophical exploration of neurobehavioral mechanisms.

Keywords

Neurostimulation Neuromodulation Electrical Stimulation Nervous System 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Gofeld is a consultant for Medtronic Inc., St. Jude Medical, and Boston Scientific (Cardiovascular Division), and has received grants from St. Jude Medical in the past. Dr. Gofeld serves as a section editor for Current Pain and Headache Reports.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol. 2013;189:2194–21201.PubMedCrossRefGoogle Scholar
  2. 2.
    Sullivan MD, Howe CQ. Opioid therapy for chronic pain in the United States: Promises and perils. Pain. 2013. doi: 10.1016/j.pain.2013.09.009.Google Scholar
  3. 3.•
    Younger JW, Chu LF, D’Arcy N, Trott K, Jastrzab LE, Mackey SC. Prescription opioid analgesics rapidly change the human brain. Pain. 2011;152(8):1803–10. The results of this study suggest that even short-term administration of opioids may irreversibly change brain gray matter in certain regions including the amygdala, hypothalamus, inferior frontal gyrus, ventral posterior cingulated, and caudal pons.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Chaparro LE, Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S. Turk DC Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev. 2013;8, CD004959. doi: 10.1002/14651858.CD004959.pub4.PubMedGoogle Scholar
  5. 5.
    Froholdt A, Reikeraas O, Holm I, Keller A, Brox JI. No difference in 9-year outcome in CLBP patients randomized to lumbar fusion versus cognitive intervention and exercises. Eur Spine J. 2012;21(12):2531–8.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Chan CW, Peng P. Failed back surgery syndrome. Pain Med. 2011;12(4):577–606.PubMedCrossRefGoogle Scholar
  7. 7.
    Poree L, Krames E, Pope J, Deer TR, Levy R, Schultz L. Spinal cord stimulation as treatment for complex regional pain syndrome should be considered earlier than last resort therapy. Neuromodulation. 2013;16(2):125–41.PubMedCrossRefGoogle Scholar
  8. 8.•
    Kumar K, Rizvi S, Nguyen R, et al. Impact of wait-times on spinal cord stimulation therapy outcomes. Pain Pract 2013. This paper illustrates how the long-term efficacy of SCS is inversely proportional to implantation delay. The key to success is early SCS implantation and adherence to rigorous patient selection. Google Scholar
  9. 9.
  10. 10.
    Ansarinia M, Rezai A, Tepper SJ, Steiner CP, Stump J, Stanton-Hicks M, et al. Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches. Headache. 2010;50(7):1164–74.Google Scholar
  11. 11.
    Schoenen J, Jensen RH, Lantéri-Minet M, Láinez MJ, Gaul C, Goodman AM, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled study. Cephalalgia. 2013;33(10):816–30.Google Scholar
  12. 12.
    Alo KM, Yland MJ, Feler C, Oakley J. A study of electrode placement at the cervical and upper thoracic nerve roots using an anatomic trans-spinal approach. Neuromodulation. 1999;2:222–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Liem L, Russo M, Huygen FJ, Van Buyten JP, Smet I, Verrills P, et al. A multicenter, prospective trial to assess the safety and performance of the spinal modulation dorsal root ganglion neurostimulator system in the treatment of chronic pain. Neuromodulation. 2013. doi: 10.1111/ner.12072.
  14. 14.
    Younger J, Aron A, Parke S, Chatterjee N. Mackey S Viewing pictures of a romantic partner reduces experimental pain: involvement of neural reward systems. PLoS One. 2010;5(10):e13309. doi: 10.1371/journal.pone.0013309.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Marineo G, Iorno V, Gandini C, Moschini V, Smith TJ. Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot randomized, controlled trial. J Pain Symptom Manage. 2012;43(1):87–95.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.University of TorontoTorontoCanada
  2. 2.St Michael’s HospitalTorontoCanada

Personalised recommendations